Eight-Week Bedaquiline-Linezolid Noninferior for TB

TUESDAY, Feb. 28, 2023 -- A strategy of eight weeks of bedaquiline-linezolid is noninferior to a standard regimen for tuberculosis, according to a study published online Feb. 20 in the New England Journal of Medicine to coincide with the annual...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news